Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab

Development of effective therapies for recurrent glioblastoma multiforme (GBM) and reliable, timely evaluation of their benefit are needed. Understanding the relationship between objective response (OR) and survival is important for determining whether OR can provide an early signal of treatment act...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Prados, Michael, Cloughesy, Timothy, Samant, Meghna, Fang, Liang, Wen, Patrick Y., Mikkelsen, Tom, Schiff, David, Abrey, Lauren E., Yung, W.K. Alfred, Paleologos, Nina, Nicholas, Martin K., Jensen, Randy, Vredenburgh, James, Das, Asha, Friedman, Henry S.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2011
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018914/
https://ncbi.nlm.nih.gov/pubmed/21084434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq151
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars